Skip to content
Brand AI

Medicilon

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2024

    Medicilon Deputy General Manager Cai Jinna's Spouse Engaged in Short-Swing Trading; Shanghai Securities Regulatory Bureau Issues Warning Letter

    The decision of the Shanghai Securities Regulatory Bureau (Hu Zheng Jian Jue [2024] No. 211) shows that Chen Minwu, spouse of Medicilon director and deputy general manager Cai Jinna, bought 3,000 shares of the company on January 12, 2022, and sold 3,000 shares the next day, constituting short-swing trading. The Shanghai Securities Regulatory Bureau issued a warning letter to Cai Jinna. Previously, the Shanghai Stock Exchange had issued a regulatory warning to her in August 2022; the short-swing trading profit of RMB 12,143.75 had been handed over to the company. Status: regulatory measure. Entities involved: Shanghai Medicilon Inc., Cai Jinna (director, deputy general manager). Scope: stock transactions by Medicilon directors, supervisors, and senior management.

    Source